Introduction: Reframing the Role of PDE-5 Inhibitors in Modern Medicine Phosphodiesterase type 5 (PDE-5) inhibitors have long been associated with the management of erectile dysfunction, yet this narrow perception obscures their broader and far more intriguing therapeutic potential. Among these agents, sildenafil has emerged as a pharmacological bridge between vascular biology and clinical innovation, particularly […]